ANTHONY LUMBAD: Open Payments
NPI 1679965693 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$219 in 11 payments from 8 companies in 2025. Trend: 2023 $103 · 2024 $103 · 2025 $219
Food & beverage: $219
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $56 |
| ABIOMED | 2 | $43 |
| BridgeBio Pharma, Inc. | 2 | $33 |
| PFIZER INC. | 2 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: SAPIEN 3 Ultra RESILIA, Attruby, ELIQUIS, CAMZYOS, Wegovy, AMVUTTRA, LEQVIO.
Industry payments across OR — which companies pay providers there.
